J.J.T.M. Heuvel

1.1k citations

22 papers · 886 indexed · h-index 16

Co-authors: Fred C.G.J. Sweep L.V.A.M. Beex Paul N. Span John A. Foekens Peggy Manders T J Benraad Anneke Geurts‐Moespot J Witte
Topics: Protease and Inhibitor Mechanisms (11 papers)Cell Adhesion Molecules Research (8 papers)Blood Coagulation and Thrombosis Mechanisms (7 papers)
Cited by: Cancer Research Immunology and Allergy Oncology
Journals: Journal of Clinical Oncology Oncogene British Journal of Cancer
Partner nations: Netherlands Denmark United States

In The Last Decade

J.J.T.M. Heuvel

22 papers receiving 855 citations

Peers

Countries citing papers authored by J.J.T.M. Heuvel

Since Specialization

Citations

This map shows the geographic impact of J.J.T.M. Heuvel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.J.T.M. Heuvel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.J.T.M. Heuvel more than expected).

Fields of papers citing papers by J.J.T.M. Heuvel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.J.T.M. Heuvel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.J.T.M. Heuvel. The network helps show where J.J.T.M. Heuvel may publish in the future.

Co-authorship network of co-authors of J.J.T.M. Heuvel

This figure shows the co-authorship network connecting the top 25 collaborators of J.J.T.M. Heuvel. A scholar is included among the top collaborators of J.J.T.M. Heuvel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.J.T.M. Heuvel. J.J.T.M. Heuvel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	GATA transcription factors in testicular adrenal rest tumours 2017 ·Endocrine Connections ·Manon Engels,Paul N. Span,Rod T. Mitchell,J.J.T.M. Heuvel,(unknown),Antonius E. van Herwaarden,Christina A. Hulsbergen‐van de Kaa,Egbert Oosterwijk,Nike Stikkelbroeck,Lee B. Smith,Fred C.G.J. Sweep,Hedi L. Claahsen‐van der Grinten	11
2	Tribbles homolog 3 denotes a poor prognosis in breast cancer and is involved in hypoxia response 2011 ·Breast Cancer Research ·(unknown),Johan Bussink,Blanca Scheijen,Irıs D. Nagtegaal,Hanneke WM van Laarhoven,James A. Raleigh,Mahesh A. Varia,J.J.T.M. Heuvel,Kasper M.A. Rouschop,Fred C.G.J. Sweep,Paul N. Span	73
3	Harmonisation of multi-centre real-time reverse-transcribed PCR results of a candidate prognostic marker in breast cancer: An EU-FP6 supported study of members of the EORTC – PathoBiology Group 2008 ·European Journal of Cancer ·Paul N. Span,Anieta M. Sieuwerts,J.J.T.M. Heuvel,F. Spyratos,Michael J. Duffy,Serenella Eppenberger‐Castori,Sophie Vacher,Kerry O’Brien,Eadaoin McKiernan,John P. Pierce,Vincent Vuaroqueaux,John A. Foekens,Fred C.G.J. Sweep,John W.M. Martens	2
4	Do the Survivin (BIRC5) Splice Variants Modulate or Add to the Prognostic Value of Total Survivin in Breast Cancer? 2006 ·Clinical Chemistry ·Paul N. Span,Vivianne C. G. Tjan‐Heijnen,J.J.T.M. Heuvel,Jacques B de Kok,John A. Foekens,Fred C.G.J. Sweep	47
5	Tissue inhibitors of metalloproteinase expression in human breast cancer: TIMP‐3 is associated with adjuvant endocrine therapy success 2004 ·The Journal of Pathology ·Paul N. Span,Raija L.P. Lindberg,Peggy Manders,V.C.G. Tjan-Heijnen,J.J.T.M. Heuvel,L.V.A.M. Beex,Fred C.G.J. Sweep	48
6	Mammaglobin Is Associated With Low-Grade, Steroid Receptor-Positive Breast Tumors From Postmenopausal Patients, and Has Independent Prognostic Value for Relapse-Free Survival Time 2004 ·Journal of Clinical Oncology ·Paul N. Span,Esmé Waanders,Peggy Manders,J.J.T.M. Heuvel,John A. Foekens,Mark A. Watson,L.V.A.M. Beex,Fred C.G.J. Sweep	65
7	E1AF Expression Levels are not Associated with Prognosis in Human Breast Cancer 2003 ·Breast Cancer Research and Treatment ·Paul N. Span,Peggy Manders,J.J.T.M. Heuvel,L.V.A.M. Beex,Fred C.G.J. Sweep	7
8	Molecular Beacon Reverse Transcription-PCR of Human Chorionic Gonadotropin-β-3, -5, and -8 mRNAs Has Prognostic Value in Breast Cancer 2003 ·Clinical Chemistry ·Paul N. Span,Peggy Manders,J.J.T.M. Heuvel,Chris M.G. Thomas,Remko R. Bosch,L.V.A.M. Beex,Fred C.G.J. Sweep	20
9	Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer 2002 ·Oncogene ·Paul N. Span,Peggy Manders,J.J.T.M. Heuvel,Chris M.G. Thomas,Remko R. Bosch,L.V.A.M. Beex,Fred C.G.J. Sweep	111
10	Prognostic impact of urokinase-type plasminogen activator receptor (uPAR) in cytosols and pellet extracts derived from primary breast tumours 2001 ·British Journal of Cancer ·J Witte,John A. Foekens,Nils Brünner,J.J.T.M. Heuvel,(unknown),Maxime P. Look,(unknown),Anneke Geurts‐Moespot,Nicolaï Grebenchtchikov,T J Benraad,Fred C.G.J. Sweep	38
11	ELISA for complexes of urokinase-type and tissue-type plasminogen activators with their type-1 inhibitor (uPA?PAI-1 and tPA?PAI-1) 1999 ·International Journal of Cancer ·(unknown),Fred C.G.J. Sweep,(unknown),Peter A. Andreasen,(unknown),(unknown),J.J.T.M. Heuvel,(unknown)	21
12	ELISA for complexes of urokinase‐type and tissue‐type plasminogen activators with their type‐1 inhibitor (uPA∼PAI‐1 and tPA∼PAI‐1) 1999 ·International Journal of Cancer ·(unknown),Fred C.G.J. Sweep,(unknown),Peter A. Andreasen,(unknown),(unknown),J.J.T.M. Heuvel,(unknown)	1
13	Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancer 1999 ·British Journal of Cancer ·J Witte,Fred C.G.J. Sweep,J.G.M. Klijn,(unknown),Harry A. Peters,Maxime P. Look,(unknown),J.J.T.M. Heuvel,Joan Bolt‐de Vries,T J Benraad,John A. Foekens	37
14	Prognostic impact of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) in cytosols and pellet extracts derived from 892 breast cancer patients 1999 ·British Journal of Cancer ·J Witte,Fred C.G.J. Sweep,J.G.M. Klijn,(unknown),Harry A. Peters,Maxime P. Look,(unknown),J.J.T.M. Heuvel,Wim L.J. van Putten,Th. J. Benraad,John A. Foekens	38
15	Complexes between urokinase-type plasminogen activator and its receptor in blood as determined by enzyme-linked immunosorbent assay 1998 ·International Journal of Cancer ·(unknown),Fred C.G.J. Sweep,Nils Brünner,J.J.T.M. Heuvel,L.V.A.M. Beex,(unknown),(unknown)	29
16	External quality assessment of trans-European multicentre antigen determinations (enzyme-linked immunosorbent assay) of urokinase-type plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) in human breast cancer tissue extracts 1998 ·British Journal of Cancer ·Fred C.G.J. Sweep,J Geurts-Moespot,(unknown),J Witte,J.J.T.M. Heuvel,Manfred Schmitt,(unknown),F. Jänicke,(unknown),John A. Foekens,Nils Brünner,G Brugal,A. Pedersen,T J Benraad	97
17	A Sensitive and Robust Assay for Urokinase and Tissue-Type Plasminogen Activators (Upa and Tpa) and Their Inhibitor Type I (Pai-1) in Breast Tumor Cytosols 1997 ·The International Journal of Biological Markers ·(unknown),Anneke Geurts‐Moespot,(unknown),J.J.T.M. Heuvel,R E Leake,Fred C.G.J. Sweep,T J Benraad	80
18	Immunoassays (ELISA) of urokinase-type plasminogen activator (uPA): Report of an EORTC/BIOMED-1 Workshop 1996 ·European Journal of Cancer ·Th. J. Benraad,J Geurts-Moespot,J Grøndahl-Hansen,Manfred Schmitt,J.J.T.M. Heuvel,J Witte,John A. Foekens,R E Leake,Nils Brünner,Fred C.G.J. Sweep	57
19	Epidermal growth factor receptor-negative tumors are predominantly confined to the subgroup of estradiol receptor-positive human primary breast cancers. 1991 ·PubMed ·P. Koenders,L.V.A.M. Beex,Anneke Geurts‐Moespot,J.J.T.M. Heuvel,(unknown),T J Benraad	72
20	Six methods for direct radioiodination of mouse epidermal growth factor compared: effect of nonequivalence in binding behavior between labeled and unlabeled ligand. 1991 ·PubMed ·(unknown),J.J.T.M. Heuvel,H A Ross,L M Swinkels,John A. Foekens,T J Benraad	26

About J.J.T.M. Heuvel

J.J.T.M. Heuvel is a scholar working on Immunology and Allergy, Cancer Research and Hematology, having authored 22 papers that have together received 886 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (11 papers), Cell Adhesion Molecules Research (8 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). The work is most often cited by research in Cancer Research (444 citations), Immunology and Allergy (142 citations) and Oncology (401 citations). J.J.T.M. Heuvel has collaborated with scholars based in Netherlands, Denmark and United States. Frequent co-authors include Fred C.G.J. Sweep, L.V.A.M. Beex, Paul N. Span, John A. Foekens, Peggy Manders, T J Benraad, Anneke Geurts‐Moespot, J Witte, Nils Brünner and Remko R. Bosch. Their work appears in journals such as Journal of Clinical Oncology, Oncogene and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact